Identification of a Cuproptosis-Related Molecular Signature for Predicting Biochemical Recurrence in Prostate Cancer.

Key Points

• The research aims to identify cuproptosis-related molecules and develop a molecular signature for predicting biochemical recurrence in prostate cancer.
• Identified cuproptosis-related molecules based on gene expression patterns.
• Developed a molecular signature using six DERRGs.
• Analyzed predictive performance for biochemical recurrence-free survival and tumor immune environment.
• Identified two key cuproptosis-related molecules.
• Developed a new molecular signature with significant predictive accuracy for biochemical recurrence.
• The signature includes six specific genes related to cuproptosis.